Effect of supragingival plaque control in smokers and never-smokers

6-month evaluation of patients with periodontitis

Sabrina Carvalho Gomes, Flávia Benetti Piccinin, Cristiano Susin, Rui Vicente Oppermann, Rosemary Adriana Chiérici Marcantonio

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: The effect of supragingival plaque control on clinical signs of periodontitis is controversial, particularly when smoking habits are considered. This study evaluated the clinical effects of supragingival plaque control on clinical signs of periodontitis in smokers and never-smokers. Methods: The following data were collected for 25 never-smokers and 25 smokers at baseline and 30, 90, and 180 days: visible plaque index (VPI), gingival bleeding index (GBI), bleeding on probing (BOP), periodontal probing depth (PD), and clinical attachment loss (CAL). After baseline examinations, supragingival scaling was performed. Oral hygiene practices were reinforced and reevaluated weekly during the experimental period. Linear models adjusted for clustering of observations within individuals were used for statistical analysis. Results: Reductions in VPI were significant for both groups, with no intergroup differences. GBI at baseline was similar between groups, and at 30, 90, and 180 days, smokers had a lower GBI than never-smokers. Significant reductions were observed in PD for shallow (1 to 3 mm), moderate (4 to 5 mm), and deep sites (≥6 mm) in both groups. CAL was significantly greater in smokers throughout the study, but gains in attachment were similar for both groups (0.71 to 1.00 mm). BOP reductions were similar in both groups. Conclusions: Supragingival plaque control resulted in significant changes in clinical parameters associated with gingivitis and periodontitis. Smoking did not affect results, regardless of initial PD.

Original languageEnglish (US)
Pages (from-to)1515-1521
Number of pages7
JournalJournal of Periodontology
Volume78
Issue number8
DOIs
StatePublished - Aug 1 2007
Externally publishedYes

Fingerprint

Periodontitis
Periodontal Index
Hemorrhage
Dental Scaling
Smoking
Gingivitis
Oral Hygiene
Habits
Cluster Analysis
Linear Models

Keywords

  • Clinical trial
  • Oral hygiene
  • Periodontitis
  • Smoking
  • Supragingival scaling

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Effect of supragingival plaque control in smokers and never-smokers : 6-month evaluation of patients with periodontitis. / Gomes, Sabrina Carvalho; Piccinin, Flávia Benetti; Susin, Cristiano; Oppermann, Rui Vicente; Marcantonio, Rosemary Adriana Chiérici.

In: Journal of Periodontology, Vol. 78, No. 8, 01.08.2007, p. 1515-1521.

Research output: Contribution to journalArticle

Gomes, Sabrina Carvalho ; Piccinin, Flávia Benetti ; Susin, Cristiano ; Oppermann, Rui Vicente ; Marcantonio, Rosemary Adriana Chiérici. / Effect of supragingival plaque control in smokers and never-smokers : 6-month evaluation of patients with periodontitis. In: Journal of Periodontology. 2007 ; Vol. 78, No. 8. pp. 1515-1521.
@article{adf3605aed694ed78cfb7d3a4981588e,
title = "Effect of supragingival plaque control in smokers and never-smokers: 6-month evaluation of patients with periodontitis",
abstract = "Background: The effect of supragingival plaque control on clinical signs of periodontitis is controversial, particularly when smoking habits are considered. This study evaluated the clinical effects of supragingival plaque control on clinical signs of periodontitis in smokers and never-smokers. Methods: The following data were collected for 25 never-smokers and 25 smokers at baseline and 30, 90, and 180 days: visible plaque index (VPI), gingival bleeding index (GBI), bleeding on probing (BOP), periodontal probing depth (PD), and clinical attachment loss (CAL). After baseline examinations, supragingival scaling was performed. Oral hygiene practices were reinforced and reevaluated weekly during the experimental period. Linear models adjusted for clustering of observations within individuals were used for statistical analysis. Results: Reductions in VPI were significant for both groups, with no intergroup differences. GBI at baseline was similar between groups, and at 30, 90, and 180 days, smokers had a lower GBI than never-smokers. Significant reductions were observed in PD for shallow (1 to 3 mm), moderate (4 to 5 mm), and deep sites (≥6 mm) in both groups. CAL was significantly greater in smokers throughout the study, but gains in attachment were similar for both groups (0.71 to 1.00 mm). BOP reductions were similar in both groups. Conclusions: Supragingival plaque control resulted in significant changes in clinical parameters associated with gingivitis and periodontitis. Smoking did not affect results, regardless of initial PD.",
keywords = "Clinical trial, Oral hygiene, Periodontitis, Smoking, Supragingival scaling",
author = "Gomes, {Sabrina Carvalho} and Piccinin, {Fl{\'a}via Benetti} and Cristiano Susin and Oppermann, {Rui Vicente} and Marcantonio, {Rosemary Adriana Chi{\'e}rici}",
year = "2007",
month = "8",
day = "1",
doi = "10.1902/jop.2007.060462",
language = "English (US)",
volume = "78",
pages = "1515--1521",
journal = "Journal of Periodontology",
issn = "0022-3492",
publisher = "American Academy of Periodontology",
number = "8",

}

TY - JOUR

T1 - Effect of supragingival plaque control in smokers and never-smokers

T2 - 6-month evaluation of patients with periodontitis

AU - Gomes, Sabrina Carvalho

AU - Piccinin, Flávia Benetti

AU - Susin, Cristiano

AU - Oppermann, Rui Vicente

AU - Marcantonio, Rosemary Adriana Chiérici

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Background: The effect of supragingival plaque control on clinical signs of periodontitis is controversial, particularly when smoking habits are considered. This study evaluated the clinical effects of supragingival plaque control on clinical signs of periodontitis in smokers and never-smokers. Methods: The following data were collected for 25 never-smokers and 25 smokers at baseline and 30, 90, and 180 days: visible plaque index (VPI), gingival bleeding index (GBI), bleeding on probing (BOP), periodontal probing depth (PD), and clinical attachment loss (CAL). After baseline examinations, supragingival scaling was performed. Oral hygiene practices were reinforced and reevaluated weekly during the experimental period. Linear models adjusted for clustering of observations within individuals were used for statistical analysis. Results: Reductions in VPI were significant for both groups, with no intergroup differences. GBI at baseline was similar between groups, and at 30, 90, and 180 days, smokers had a lower GBI than never-smokers. Significant reductions were observed in PD for shallow (1 to 3 mm), moderate (4 to 5 mm), and deep sites (≥6 mm) in both groups. CAL was significantly greater in smokers throughout the study, but gains in attachment were similar for both groups (0.71 to 1.00 mm). BOP reductions were similar in both groups. Conclusions: Supragingival plaque control resulted in significant changes in clinical parameters associated with gingivitis and periodontitis. Smoking did not affect results, regardless of initial PD.

AB - Background: The effect of supragingival plaque control on clinical signs of periodontitis is controversial, particularly when smoking habits are considered. This study evaluated the clinical effects of supragingival plaque control on clinical signs of periodontitis in smokers and never-smokers. Methods: The following data were collected for 25 never-smokers and 25 smokers at baseline and 30, 90, and 180 days: visible plaque index (VPI), gingival bleeding index (GBI), bleeding on probing (BOP), periodontal probing depth (PD), and clinical attachment loss (CAL). After baseline examinations, supragingival scaling was performed. Oral hygiene practices were reinforced and reevaluated weekly during the experimental period. Linear models adjusted for clustering of observations within individuals were used for statistical analysis. Results: Reductions in VPI were significant for both groups, with no intergroup differences. GBI at baseline was similar between groups, and at 30, 90, and 180 days, smokers had a lower GBI than never-smokers. Significant reductions were observed in PD for shallow (1 to 3 mm), moderate (4 to 5 mm), and deep sites (≥6 mm) in both groups. CAL was significantly greater in smokers throughout the study, but gains in attachment were similar for both groups (0.71 to 1.00 mm). BOP reductions were similar in both groups. Conclusions: Supragingival plaque control resulted in significant changes in clinical parameters associated with gingivitis and periodontitis. Smoking did not affect results, regardless of initial PD.

KW - Clinical trial

KW - Oral hygiene

KW - Periodontitis

KW - Smoking

KW - Supragingival scaling

UR - http://www.scopus.com/inward/record.url?scp=34548082754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548082754&partnerID=8YFLogxK

U2 - 10.1902/jop.2007.060462

DO - 10.1902/jop.2007.060462

M3 - Article

VL - 78

SP - 1515

EP - 1521

JO - Journal of Periodontology

JF - Journal of Periodontology

SN - 0022-3492

IS - 8

ER -